Providing evidence-based information in a practical, easy-to-read format for practicing clinicians, investigators, industry scientists, and other entities involved in the field of neuroscience
Current Issue • July–September 2024
Exploring the Complex Relationship Between Antiepileptic Drugs and Suicidality: A Systematic Literature Review
by Aksha M. Memon, MBBS, MD, MPH; Jigar Katwala, MBBS, MD; Clarice Douille, BS; Caitlin Kelley, BS; and Varun Monga, MD Dr. Memon is with Creighton University School of Medicine in Phoenix, Arizona. Mses. Douille [...]
Risk Management: Treating Patients at Risk for Suicide: Part 2
by Akemini “Kem” Isang, RN, JD Ms. Isang is a Risk Manager at Professional Risk Management Services (PRMS). Funding: No funding was provided for the preparation of this article. Disclosures: The author is an employee [...]
Letter to the Editor: Olanzapine-induced Endoplasmic Reticulum Stress Induces Atypical Diabetes and Diabetic Ketoacidosis
Funding/financial disclosures. The author has no conflicts of interest relevant to the content of this letter. No funding was received for the preparation of this letter. Innov Clin Neurosci. 2022;19(10–12):8–9. Dear Editor: Patients exposed to [...]
Major Depressive Disorder, Suicides, and the Role of Dimensional Psychiatry for Triaging in Primary Care Settings: A Case Series Retroanalysis
by Atmaram Yarlagadda, MD; Adrian R. Johnson, LCSW, MSW; Cheyenne M. Bickerstaff, BS; Joseph R. Yancey, MD, MBA; Samuel L. Preston, DO; Liquori L. Etheridge, LCSW; Michelle Maddalozzo, LCSW; Samuel Ochinang, LCSW; Rosemary A. Jackson, DNP, PMHNP-BC; and [...]
Executive Functioning in Children and Adolescents with ADHD and Disruptive Behavior Disorders
by Rosa Elena Ulloa Flores, MD, PhD; Ricardo Díaz Sánchez, BS; Francisco R. de la Peña, MD, MS; Marcos F. Rosetti Sciutto, PhD; Lino Palacios Cruz, MD, PhD; and Pablo Mayer Villa, MD, MS Dr. Ulloa [...]
Olfactory Dysfunction in Incidental Lewy Body Disease and Parkinson’s Disease: An Update
by Shemonti Hasan, MD; Charles H. Adler, MD, PhD; Nan Zhang, MS; Geidy E. Serrano, PhD; Lucia I. Sue, BS; Holly A. Shill, MD; Shyamal H. Mehta, MD, PhD; Thomas G. Beach, MD, PhD; and Erika D. [...]
Impact of COVID-19 Pandemic on Psychiatric Patients at Clinical Trial Sites
by Maria Fe Garcia-Rada, MPS, and Robert E. Litman, MD Ms. Garcia-Rada and Dr. Litman are with CenExel CBH Health in Gaithersburg, Maryland. Dr. Litman is with Georgetown University Medical School in Washington, DC. Funding: [...]
Stroop Test for Parkinson’s Disease with Deep Brain Stimulation: A Systematic Review
by Amer Cavalheiro Hamdan, PhD, and Mariana Drabik Vieira, MSc Dr. Hamdan is with the Graduate Program in Psychology, Department of Psychology, Federal University of Parana in Curitiba, Brazil. Dr. Vieira is a psychologist, candidate [...]
Past Articles
The Impact of Psilocybin on Patients Experiencing Psychiatric Symptoms: A Systematic Review of Randomized Clinical Trials
by Waguih William IsHak, MD, FAPA; Paloma Garcia, BS Candidate; Rachel Pearl, MD; Jonathan Dang, MD; Catherine William, BS; Jayant Totlani, BS, DO candidate; and Itai Danovitch, MD, MBA Drs. IsHak, Pearl, Dang, and Danovitch [...]
Seizure and Other Catastrophes due to Bupropion Overdose: Recent Case Report and Review of Published Cases
by Isha Snehal, MD; Garret Lorenzen, MS; and Ashish Sharma, MD Dr. Snehal is with Department of Neurological Sciences, University of Nebraska Medical Center in Omaha, Nebraska. Mr. Lorenzen is with College of Medicine, University [...]
Risk Management: Treating Patients at Risk for Suicide: Part 1
by Donna Vanderpool, MBA, JD Ms. Vanderpool is Director of Risk Management at Professional Risk Management Services (PRMS). Funding: No funding was provided for the preparation of this article. Disclosures: The author is an employee [...]
Letter to the Editor: Open Bite Malocclusion Following Aripiprazole Treatment in Children and Adolescents
Funding/financial disclosures. The author has no conflicts of interest relevant to the content of this letter. No funding was received for the preparation of this letter. Innov Clin Neurosci. 2023;20(4–6):9–10. Dear Editor: Aripiprazole is one [...]
Letter to the Editor: What About the Hippotherapy Benefit-cost Ratio in Everyday Clinical Practice? The Physician Point of View
Funding/financial disclosures. The authors have no conflicts of interest relevant to the content of this letter. No funding was received for the preparation of this letter. Innov Clin Neurosci. 2023;20(4–6):8. Dear Editor: Hippotherapy is [...]
Remote Cognitive Therapeutic Exercise in Facial Nerve Palsy Rehabilitation: Pandemic Tips and Tricks
by Filippo Cavallaro, PT; Simona Portaro, MD, PhD; Teresa Pintaudi, PT; Mariachiara Ceccio, PT; and Angelo Alito, MD All authors are with the University of Messina in Messina, Italy. Funding: No funding was provided for [...]
Special Challenges in Pediatric Drug Development: First of Three Sets of Expanded Proceedings from the ISCTM Autumn Conference on Pediatric Drug Development
by Philip D. Harvey, PhD; Joan Busner, PhD; Gahan Pandina, PhD; H. Gerry Taylor, PhD; Meg Grabb, PhD; and Joohi Jimenez-Shahed, MD Dr. Harvey is with Department of Psychiatry, University of Miami Miller School of [...]
Implications of Pediatric Initiatives on CNS Drug Development for All Ages—2020 and Beyond: Second of Three Sets of Expanded Proceedings from the 2020 ISCTM Autumn Conference on Pediatric Drug Development
by Gahan Pandina, PhD; Joan Busner, PhD; Joseph P. Horrigan, MD; Christine McSherry, RN, BSN; Alison Bateman-House, MA, MPH, PhD; Luca Pani, MD; and Judith Kando, PharmD, BCPP Dr. Pandina is with Janssen Pharmaceuticals in Titusville, [...]